The University of Chicago Header Logo

Connection

Douglas Kyle Hogarth to Molecular Targeted Therapy

Back to Details
This is a "connection" page, showing publications Douglas Kyle Hogarth has written about Molecular Targeted Therapy.
Douglas Kyle Hogarth
Connection Strength
0.041
Molecular Targeted Therapy
  1. Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease. Cancer Discov. 2021 02; 11(2):308-325.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.